The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/foc.2.2.210

Delirium, dementia, and other cognitive disorders represent an increasingly important focus of clinical research and practice. In this review, the authors survey recent developments in our understanding of these disorders. Delirium is now more frequently recognized as an important contributor to morbidity and as a factor in prognosis for patients in a number of treatment settings, particularly in the geriatric population. Early detection and aggressive treatment of delirium contribute to shorter hospital stays and lower treatment costs. Delirium is often confused with other disorders of cognitive function, such as dementia. The four most common dementia syndromes, Alzheimer’s disease, vascular dementia, Lewy body dementia, and frontotemporal dementia, are explored in this review. A greater understanding of the genetic risks and the neuropathological findings of these syndromes has led to novel therapeutic strategies involving interventions at critical points along the cascade to neuronal cell death. These approaches have opened new avenues of inquiry for future developments.